Odorant stimulation elicits an odor-specific pattern of glomerular activation in the antennal lobe (AL) of the honey bee (Joerges et al. 1997; Galizia et al. 1999b). We recorded the glomerular response to the odorants 1-hexanol (10−2), 2-heptanone (10−2) and 1-nonanol (concentration series 10−4, 10−3 and 10−2). Upon stimulation with an odorant, a characteristic glomerular response pattern was visible across the AL (Fig. 1c), with some glomeruli increasing, and some decreasing calcium concentration (Fig. 1d). Calcium increases were generally steep, with a slower decay phase after stimulus offset. Odor-response time courses differed for different glomeruli, some with a slow decay, some with a faster decay (Fig. 1c, d). The decrease of intracellular calcium concentration in some glomeruli was most likely due to a closing of calcium channels, while calcium pumps were still active. Given that resting calcium levels, which we measure as average calcium level, are generally low in neurons, the absolute values of calcium decrease were not high, as visible from the small downward deflection in the respective traces (Fig. 1d). When no odorant was given, glomeruli had constantly fluctuating background calcium concentration levels (Fig. 1e). These fluctuations were much smaller than odor responses (compare the ordinate axis in Fig. 1d and e), and the correlation across glomeruli was low, as previously reported (Galan et al. 2006).
Octopamine increases background activity in projection neurons
Superfusing the brain with OA solution led to changes in background activity. Calcium fluctuations increased both with 1 mM OA (Fig. 2b) and with 10 mM OA (Fig. 2c). These fluctuations came back to baseline after OA was washed out. Furthermore, overall calcium levels dropped, in particular with 10 mM OA, as visible in Fig. 2c by the lower level of the curve. Across animals, the increase in calcium fluctuations was significant for 1 mM OA and for 10 mM OA (Fig. 2e), while the drop in overall calcium levels was only significant for 10 mM OA (Fig. 2f). The simultaneous increase in background activity and decrease in calcium levels (e.g. Fig. 2c) indicate that changing background activity in projection neurons is not caused by intrinsic mechanisms of the PNs themselves, but rather by synaptic input from the AL network.
Octopamine modulates the odor response by inducing variable changes in glomerular activity
Odors elicit complex patterns of calcium increase and decrease across glomeruli (Figs. 1c, 3a). The most characteristic property for each glomerulus is the response magnitude. Therefore, we quantified response magnitude across odors and glomeruli, and across identified glomeruli in different animals. We found that applying 1 mM OA modified the response patterns: some glomeruli increased their response, whereas other glomeruli decreased the response. Similarly, response magnitude changed after application of 10 mM OA. For example, glomerulus C45 increased its odor response considerably to 2-heptanone and to 1-hexanol (Fig. 3b, c). This was the strongest glomerulus for these two odors. However, glomerulus A33, which was the strongest glomerulus in the 1-nonanol response pattern, decreased its response to 1-nonanol after application of OA. Thus, the strongest glomeruli increased their responses for some odors, and decreased their responses for other odors. The effect on each glomerulus was odor-specific. For example, responses in glomerulus A17 decreased with OA treatment when 1-nonanol was given, but did not change for 1-hexanol (Fig. 3c, d). Indeed, the OA effect was not only odor-specific, but also concentration-dependent. For example, A17 increased its response to 1-nonanol at an odor concentration of 10−4, but decreased its response to the same odor at 10−2 (suppl. Fig. S1). A two-way ANOVA with the factors treatment and odors (with the different concentrations of 1-nonanol treated as different odors) found significant differences for the levels of treatment (F = 28.4, p < 0.001, i.e. OA had an effect) as well as for the levels of odor (F = 255.1, p < 0.001, i.e. different odors elicit different response patterns). Importantly, however, we found a significant interaction between odor and treatment (F = 4.2, p < 0.001), indicating that octopamine does not affect the response to all odors the same way. With OA superfusion the responses increased to the odors 1-hexanol and 2-heptanone as well as to 1-nonanol at concentrations of 10−3 and 10−4, but the responses to 1-nonanol 10−2 were either not affected (first stimulation) or reduced (second stimulation) in the presence of 10 mM OA (Fig. 4). The reduced effect with the first nonanol stimulation might be caused by the shorter time that octopamine had been present in the bath during this stimulation.
These observations indicate that increase or decrease in projection neuron responses within a glomerulus after OA treatment is not a property of that glomerulus, but rather a property of the AL network. The most prominent effect was that purely negative odor responses only rarely occurred under OA treatment: almost all negative responses reverted to positive ones under different treatment conditions.
The effect of octopamine depends on the strength of the initial odor response
We noted that strong odor responses were less likely to be modulated by OA treatment than weak odor responses. To test this, we created three groups of glomeruli based on their response strength to each particular stimulus: negative, weak, and strong (39 classified responses from 13 bees, N = 13 for each group). We chose 2.5 × mean standard deviation of the background activity, measured during 6 s before odorant onset, as a threshold. Glomeruli with a mean odor response that was below threshold before octopamine application were defined as weak glomeruli, glomeruli with an initial response above threshold as strong glomeruli. Glomeruli responding with a decrease in calcium concentration formed the “negative” group. Across all odors, concentrations and animals, the increased response for weak responses and for intermediate responses was significant, but no significant effect was visible for high responses (Fig. 5a). Specifically, inhibited glomeruli not only showed less negative responses, but generally even positive responses to odorant stimuli when 10 mM of octopamine was applied (e.g. A21 and A37 in Fig. 3b), an effect that was highly significant (Tukey HD following Friedman repeated measures ANOVA, χ2 = 23.7, p < 0.001). The effect was not reversible within 10 min. The observed switch from calcium decrease to calcium increase in the odor responses suggests a strong decrease in inhibitory input to a glomerulus. Weak glomeruli significantly increased their odor responses after application of 10 mM octopamine (Fig. 5a, Tukey HSD following Friedman repeated measures ANOVA, χ2 = 18.5, p < 0.001). In strong glomeruli we observed no clear increase in mean odor response but rather a tendency to decrease the odor response in the presence of OA (Fig. 5a). However, this decrease in mean odor response was not statistically significant (one-way ANOVA, F = 1.277, p = 0.314).
Given that in the control situation, when the entire experiment was done with saline treatment rather than OA treatment, the negative glomerular responses also became positive, albeit after a longer time than in the OA case (Fig. 5b, 23 classified responses from 8 bees), it appears that, at least for the calcium-decrease case, there may be two (or more) overlapping mechanisms: a reduction of negative responses over long measurement times with repeated stimulation and recording (Fig. 5b), and an immediate decrease due to OA treatment (Fig. 5a).
The effect of octopamine is variable across animals
For further analysis, we performed a two-way ANOVA with the factors treatment (with or without OA) and glomerulus (glomerular identity) and found significant differences for both factors, but no interaction between factors (two-way ANOVA, p
treatment = 1.1e−08; p
glomerulus < 2.2e−16; p
interaction = 1). These results again show that octopamine treatment led to a significant difference in mean odor response. Additionally, it shows that the measured glomeruli differed significantly in their mean odor responses, which is not unexpected as all glomeruli have an individual odor-response profile. However, the lack of interaction between factors strengthens the hypothesis that glomerular identity did not determine the response to OA treatment. Moreover, when pooling individual glomeruli across animals, we found significant octopamine-induced changes in mean odor response across odors only in two glomeruli, namely in glomeruli 37 and 49 (Tukey HSD following Friedman repeated measures ANOVA, χ
237
= 14.8, p
37 = 0.002 χ
249
= 20.6, p
49 < 0.001; to adjust for multiple testing, significance level was corrected by use of Bonferroni-correction; compare with suppl. Fig. S2). Thus, most glomeruli could both increase or decrease activity in the presence of octopamine.
The octopamine effect is a network effect
Next, we investigated whether glomeruli had stereotypical responses to OA treatment. Figure 6 shows bar-plots of odor-response differences for each odor. What is apparent is that the variability is high. Importantly, not even the polarity is uniform. For example, glomerulus A30 showed all ranges of increases and decreases of responses to 1-nonanol after OA treatment, as did glomerulus A18 to 1-hexanol, or glomerulus A33 to 2-heptanone. Weak and strong glomeruli were equally variable (e.g. A33 to 1-nonanol as a strong glomerulus). This variability indicates that OA may act on a network that is not innate, but rather the result of plasticity and/or genetic variability, and thus variable across animals.
OA acts on receptors that increase intracellular calcium concentration. Since we found both response increases and response decreases, it is unlikely that receptors on PNs contribute significantly to the effects shown here. In order to test this explicitly, we superfused the brain with caffeine, which leads to a general increase in intracellular calcium. This treatment led to a general increase in odor responses (at 5 mM caffeine), or a general decrease in odor responses (at 20 mM caffeine), but never to a complex pattern of increases and decreases in different glomeruli (suppl. Fig. S3). Thus, the OA effect reported here does not result from a general intracellular calcium increase, but rather must be a network-specific effect.
The role of AmOA1
All results so far indicated that OA acts as a modulator within the AL. However, other explanations are also possible. In particular, OA could have nonspecific effects on other biogenic amine receptors, e.g. tyramine receptors, which share a high sequence similarity. Furthermore, OA may act in brain areas other than the ALs, and the effects seen here might be mediated by neural feedback connections into the AL. In order to elucidate whether the observed effects indeed originate within the AL, and are caused by OA receptors, we downregulated the expression of the OA receptor AmOA1 using RNA interference. We injected either Amoa1 or control (Dmfred) dsRNA, in addition, a third group of animals either underwent surgery but was not injected (surgery, Fig. 7a–d) or was injected with the injection buffer used to dilute the dsRNA (Fig. 7e). We injected the dsRNA into the right ALs, and 24 h later recorded spontaneous activity and odor responses. At the end of the experiment, ALs were dissected and used for western blot analysis. Injection of Amoa1, but not control dsRNA, led to a significant reduction in AmOA1 receptor protein levels (suppl. Fig. S4).
Background activity increased in control dsRNA animals in the presence of octopamine (Tukey HSD following Friedman repeated measurement ANOVA χ2 = 84.305 p < 0.001, Fig. 7a; AmOA1 dsRNA: 192 glomeruli from 13 bees; surgery control: n = 207 from 13 bees, control dsRNA: n = 169 from 10 bees). However, animals that had been treated with Amoa1 dsRNA did not show an increase in background activity in presence of octopamine, but there was a significant increase in background activity after the washout. Background calcium levels (i.e. mean spontaneous activity) were not affected by injection of either Amoa1 or control dsRNA (Fig. 7b). Sorting glomeruli by response strength (compare with Fig. 5) confirmed a strong increase in responses, in particular for inhibited and weak glomeruli, in the untreated (surgery or injection buffer) and in the control dsRNA treatment (Fig. 7c, d; AmOA1: 39 classified responses, 13 negative, 13 strong, 13 weak from 13 bees; control dsRNA: n = 30 responses from 10 animals; surgery: n = 39 from 13 animals. Same animals for 1 mM OA and for 10 mM OA. Figure 7e: AmOA1: 27 classified responses from 9 bees; control dsRNA: n = 30 responses from 10 animals; surgery: n = 26 from 9 animals). In contrast, after Amoa1 dsRNA injection, there was only a weak and non-significant odor-response increase in inhibited and weak glomeruli. Thus, Amoa1 dsRNA injection almost completely abolished the OA superfusion effect, indicating that AmOA1 receptors within the AL were responsible for the observed modulations provoked by OA.